戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tion and 10-2 VF MD (P < .0001 better, worse eye).
2 odel, the Drosophila melanogaster developing eye.
3 e is suppressed due to inputs from the other eye.
4  with 2.2 +/- 1.2 IOP-lowering surgeries per eye.
5 in a sub-retinal pigment shield in an insect eye.
6 weakening of the medial IR in the hypotropic eye.
7 dian BCVA was 43 letters in the intervention eye.
8 up-to-disc ratio of 0.85 or higher in either eye.
9 en PRO scores and time to late AMD in either eye.
10 iological signals imperceptible to the human eye.
11  outer retinal layers of 25% of healthy aged eyes.
12 eyes as compared with PXG, PACG, and healthy eyes.
13 r with Pentacam HR in keratoconus and normal eyes.
14 P = .0076, respectively) compared to control eyes.
15 without a difference between PXS and control eyes.
16 the relationship between them in normal Thai eyes.
17 een fellow eyes and repeated measures within eyes.
18 cs were compared between uveitis and control eyes.
19 f force-carrying beams that emanate from the eyes.
20 D) on Humphrey Visual Field Analyzer in both eyes.
21                                        Seven eyes (10.6%) required repeat intervention for IOP contro
22 n group I. late recurrent VH occurred in two eyes (11.8%) in group II, IVA was given with complete cl
23 coverage in 1 eye (6%), and no coverage in 2 eyes (12%).
24                               Of these, 2187 eyes (12.4%) returned to the operating room for cataract
25                                Of these, 320 eyes (13.7%) underwent SB, 1200 eyes (51.4%) underwent P
26                     Glaucoma developed in 31 eyes (16%) with 5- and 10-year incidence rates of 12% an
27                Vitrectomy was done for three eyes (17.6%) due to recurrent non-resolving VH in group
28 e 38 eyes of 38 patients, an equal number of eyes (19 in each arm) were treated with standard-fluence
29                       Treatment failed in 37 eyes (23.7%), with a 5-year survival rate of 68.0% and a
30 operating room for cataract surgery, and 643 eyes (3.7%) returned to the operating room for a noncata
31 actional retinal detachment (RD) in her left eye, 3 years after the last intra-arterial chemotherapy
32                                          674 eyes (337 with PACD, 337 without PACD) from 674 subjects
33 SB, 1200 eyes (51.4%) underwent PPV, and 815 eyes (34.9%) underwent PPV/SB.
34                  In addition, in 47 distinct eyes, 4181 spectral-domain OCT slices were retrospective
35                      A total of 1158 of 2620 eyes (44%) with primary RRD were pseudophakic.
36           Visual axis opacity occurred in 67 eyes (45%), typically within the first postoperative yea
37                 The BLF IOL was used in 5425 eyes (47.6%), and the non-BLF IOL was used in 5972 eyes
38 f these, 320 eyes (13.7%) underwent SB, 1200 eyes (51.4%) underwent PPV, and 815 eyes (34.9%) underwe
39 47.6%), and the non-BLF IOL was used in 5972 eyes (52.4%).
40                               Thirteen of 23 eyes (57%) demonstrated RD with a mean time of 120 days
41 flap in 14 eyes (82%), partial coverage in 1 eye (6%), and no coverage in 2 eyes (12%).
42 o 15 mmHg as compared with nepafenac-treated eyes (6 eyes vs. 1 eye; P = 0.04); no eyes showed IOP el
43                               A total of 100 eyes (62% were female participants) were evaluated.
44                             A series of 1000 eyes (738 patients) underwent DMEK mainly for Fuchs endo
45 ete coverage of the MH by the ILM flap in 14 eyes (82%), partial coverage in 1 eye (6%), and no cover
46 .33; P < 0.001); and ME from NIU, -0.38 (198 eyes; 95% CI, -0.49 to -0.26; P < 0.001).
47 , -0.61 to -0.51; P < 0.001); DME, -0.50 (91 eyes; 95% CI, -0.64 to -0.33; P < 0.001); and ME from NI
48 n coefficients were: ME from RVO, -0.56 (774 eyes; 95% confidence interval [CI], -0.61 to -0.51; P <
49                    One hundred seventy-eight eyes (96 children) were identified with a median age of
50 ary, and triggers summer biology through the eyes absent/thyrotrophin (EYA3/TSH) pathway.
51 hysicians should be aware of the risk of dry eye after ptosis surgery and discuss dry eye as a compli
52 ated by 135 mum more than in their untreated eyes after 2 weeks of FD.
53                  Our results in glaucomatous eyes also indicate that ILM macrophage cells appear to p
54 had an Nd:YAG capsulotomy in the Vivinex XY1 eye and 18.6% had a capsulotomy in the AcrySof SN60WF ey
55 g and the Japanese group engaging in greater eye and central face looking.
56 rected visual acuity was 20/100 in the right eye and counting fingers on the left.
57  103 proteins individually in the Drosophila eye and identify several new molecules that control eye
58  precise biological function of HtrA1 in the eye and its contribution to disease etiologies remain un
59           Data were grouped according to the eye and the medication so that an eye treated with a par
60        Visual disturbances, contusion of the eye and/or adnexa, open globes and open wounds of ocular
61 n presented with gradual vision loss in both eyes and nyctalopia for 2 years.
62 cts to adjust for correlation between fellow eyes and repeated measures within eyes.
63 ), worsening clinical examination results (2 eyes), and retinal detachment (1 case).
64 nt of 15 letters or more in the intervention eye, and 3 participants lost more than 15 letters by mon
65  immune privileged sites such as the testes, eye, and placenta.
66 n was lower in all ATD groups versus control eyes, and correlated only with GC area.
67 ling emotions, with the act of narrowing the eyes appearing to be associated with positive emotional
68                                          The eyes are important in signalling emotions, with the act
69 dry eye after ptosis surgery and discuss dry eye as a complication of MMCR surgery with their patient
70  mixed-model analysis was performed with the eye as the unit of analysis, with crossed random effects
71     Lamina cribrosa depth was larger in POAG eyes as compared with PXG, PACG, and healthy eyes.
72               Median VA of the better-seeing eye at final study visit closest to 5 years of age with
73   Visual acuity was better in the subsequent eye at presentation (mean, 20/62 vs. 20/149; P < 0.001)
74     Main outcome measures were proportion of eyes at 1-year with (1) no 2 consecutive IOP readings >1
75 ed treatment success in 70%, 45%, and 27% of eyes at 6, 12, and 24 months post-SLT, respectively.
76 ntral involvement is present in one third of eyes at the outset (similar to pure GA) and increases li
77 ssible to obtain pre-symptomatic tissue from eye bank donors to probe how gene expression changes pre
78   We calculated GA area growth rate for each eye based on the first and last visit.
79 eye underwent enucleation at 6 months, and 1 eye became phthisical 1 year after endophthalmitis.
80  describe the ultrastructural changes in the eye between day and night.
81 m male mice ~48 h after they learned a delay eye-blink conditioning task.
82 ved outcomes for spherical and toric IOLs in eyes both with and without prior refractive surgery when
83 cs of retinal macrophage cells in live human eyes, both healthy and diseased, with the unique capabil
84 mined not just by the light that strikes our eyes, but also strongly by our prior knowledge and expec
85  chronic PAMM lesions was evaluated for both eyes by the revision of cross-sectional OCT images of 6-
86                                    To inform eye-care policy we quantified the pattern of vitreo-reti
87 ediated knockdown of Tom70 in the developing eye causes roughening and synaptic transmission defect,
88 sculature, like that of the yolk sac and the eye choriocapillaris and hyaloid vascular systems, devel
89 formed vitrectomies at the Geneva University Eye Clinic.
90 rs, significantly lower cpCD was found in ED eyes compared with AD eyes in mild glaucoma (mean, 42.2%
91 h was analyzed relative to treated vs fellow eye, contact lens (CL) vs intraocular lens (IOL), visual
92 cular pressure (IOP), clinical presentation, eye culture results, and treatments performed.
93 n of healthy persons more susceptible to dry eye (DED) symptoms developing after surgery remains an u
94                                Three re-DMEK eyes developed graft failure, all achieving final BCVA <
95  identify several new molecules that control eye development.
96                              Anti-VEGF-naive eyes diagnosed with nAMD that commenced treatment betwee
97  case, where the refraction power of the two eyes differs, an amblyopia-like state develops in which
98 ologous serum-based eye drops for severe dry eye disease and 4 studies of persistent epithelial defec
99 he prevalence as well as the severity of dry eye disease increase with age.
100 80 study participants had referable diabetic eye disease, 13.3% had vision-threatening disease, and 2
101 approach in the treatment of age-related dry eye disease.
102 redistribution resulting from inter-saccadic eye drifts, revealing a continuum in the modulations giv
103 in-person counseling session 6 months later, eye drop administration was video recorded.
104 s, patient factors associated with increased eye drop cost included older age, female gender, and rac
105          A significant increase was found in eye drop instillation self-efficacy from an average scor
106 D claims were used to extract information on eye drop prescriptions that were filled during the posto
107                                              Eye-drop formulations should hold as high a concentratio
108  However, the rapid clearance of Sunb-malate eye drops administered through topical instillation limi
109 studies of the use of autologous serum-based eye drops for severe dry eye disease and 4 studies of pe
110                                          One eye each of 39 glaucoma and 31 age-matched normal partic
111                                          One eye each of 97 glaucoma patients (median mean deviation,
112 antly associated with an increase in dilated eye examination rates within the first 2 years after imp
113 ivalent to detecting ODH in 45% of 3 monthly eye examination visits, was associated with significantl
114 ox proportional hazards analysis showed that eyes experiencing HP had a marginally higher risk of fai
115 nurse-led structured evaluation (blood/urine/eye/feet) in public and private outpatient clinics and d
116 rsal nucleus of the thalamus (MD) to frontal eye field (FEF) carries such a CD for saccadic eye movem
117 e of vertebrate evolution when image-forming eyes first emerged.
118  along with decreasing visual acuity in both eyes following 3 months of PTX therapy for recurrent liv
119 servational study in 59 aniridic and aphakic eyes for ArtificialIris (AI) and IOL reconstruction.
120 criminating between healthy and glaucomatous eyes for cpCD was higher for ED (0.95) compared with AD
121 mutated genes involved in cavefish vestigial eye formation have not been characterized.
122                              It included 205 eyes from 205 patients distributed in 82 normal corneas,
123                                  Forty-seven eyes from 24 patients were included in this study.
124                                A total of 31 eyes from 31 consecutive patients with advanced Coats di
125                    Three hundred twenty-nine eyes from 329 patients were included in this study: 90 n
126                                   Of the 137 eyes graded as showing attached vitreous on OCT, 129 eye
127  (P < 0.0001), respectively, in the surgical eye group.
128                                          One eye had vitreomacular traction and a remote history of b
129 ded as showing attached vitreous on OCT, 129 eyes had attached vitreous at the time of surgery (true-
130                                A total of 78 eyes had hypersecretory MGD; 49 eyes had nonobvious MGD;
131 ecretory MGD; 49 eyes had nonobvious MGD; 66 eyes had hyposecretory MGD; and 254 eyes had obstructive
132  total of 78 eyes had hypersecretory MGD; 49 eyes had nonobvious MGD; 66 eyes had hyposecretory MGD;
133  MGD; 66 eyes had hyposecretory MGD; and 254 eyes had obstructive MGD.
134 me of surgery (true-negative results), and 8 eyes had pre-existing PVD at the time of surgery (false-
135                            Overall, 62.1% of eyes had spherical equivalent within +/-0.5 D and 80.9%
136     Cluster analysis of this large cohort of eyes identified peripheral lesions and intraocular infla
137 y eye, those who experienced significant dry eye (ie, daily/almost daily dry eye) more often agreed t
138 in patients with bilateral PACS and the PACS eye in asymmetrical disease (primary angle closure in fe
139 e to month 24 data from all randomized study eyes in HARBOR with both FFA and SD OCT data were analyz
140 r cpCD was found in ED eyes compared with AD eyes in mild glaucoma (mean, 42.2% [95% confidence inter
141                                        Right eyes in patients with bilateral PACS and the PACS eye in
142                                              Eyes in the highest IOP PRS quintile showed an early mor
143  Approximately 7.6%, 12.2%, and 13.8% of all eyes in this study needed glaucoma surgery at 1-, 5-, an
144 coma-induced visual impairment in at least 1 eye increased from 0.00 after 5 years to 0.22 (95% confi
145 e develops in which the foveal region of one eye is suppressed due to inputs from the other eye.
146 2 subjects with manifest keratoconus in both eyes (KCE cohort), 9 subjects with very asymmetric ectas
147 ression rates (in decibels per year) between eyes likely are correlated.
148 arly DME gained 10 or more letters and fewer eyes lost 10 or more letters compared with eyes with lat
149 ield progression in glaucoma can affect both eyes, meaning that progression rates (in decibels per ye
150 h a complaint of increasing pain in the left eye more than the right, along with decreasing visual ac
151 nificant dry eye (ie, daily/almost daily dry eye) more often agreed that living with Sjogren syndrome
152                     Overall, we suggest that eye morphology and retinal topography in flamingos refle
153 essed parameters such as lethality, wing and eye morphology, neuromuscular junction morphology, bang
154 whether learning is facilitated by non-rapid eye movement (NREM) sleep or by REM sleep, whether it re
155                               Notably, rapid eye movement (REM) sleep regulates emotional memory, and
156                                 During rapid eye movement (REM) sleep, behavioral unresponsiveness co
157 y from kinematic features, 70% accuracy from eye movement features and 78% accuracy from combined fea
158 est when stimuli are presented closer to the eye movement onset time.
159 es become less synchronized during non-rapid eye movement sleep after sleep deprivation at the networ
160 ry can include prodromal features (eg, rapid eye movement sleep behavior disorder, hyposmia, constipa
161 th improved task performance, and inhibiting eye movements in humans impaired navigation precision.
162 ively sample their environment with saccadic eye movements to bring relevant information into high-ac
163 tinuum in the modulations given by different eye movements, with oculomotor transitions primarily act
164 luding automated detection of slow waves and eye movements.
165 n shift covertly, decoupled from programming eye movements.
166 at the hippocampus coordinates memory-guided eye movements.
167 e field (FEF) carries such a CD for saccadic eye movements.
168                                              Eye-movements were recorded using a remote eye tracker.
169 lement, hopper(Bd-we), isolated from a white eye mutant strain had an intact transposase reading fram
170                                          One eye of each pair was cross-linked by 0.1% riboflavin in
171  This prospective study enrolled 100 healthy eyes of 100 patients, with ages ranging from 23 to 65 ye
172                               A total of 111 eyes of 111 patients were treated for endophthalmitis af
173                                   Thirty-one eyes of 18 patients required glaucoma surgery with 2.2 +
174            The study population included 343 eyes of 185 subjects with hospital record diagnoses of M
175       Swept-source OCT was carried out in 30 eyes of 20 patients with choroidal coloboma.
176                                  Of these 38 eyes of 38 patients, an equal number of eyes (19 in each
177 E) in 836 spectral-domain OCT slices from 44 eyes of 39 patients.
178               PatientPopulation: Forty-three eyes of 43 patients with age-related cataract and CA(tot
179                                A total of 92 eyes of 47 patients (31 females) with mean age of 48.0 +
180         A total of 491 SDOCT volumes from 87 eyes of 54 patients were assessed with a median follow-u
181 ted during 23G pars plana vitrectomy from 54 eyes of 54 patients with different RD types, such as rhe
182                               A total of 102 eyes of 63 patients were included in this study.
183                                  Ninety-four eyes of 66 patients received an FAc implant.
184 l nonexudative neovascular AMD in the fellow eyes of patients with unilateral exudative AMD ranged fr
185                               We imaged both eyes of preterm infants with an investigational nonconta
186  found overlying type 1 MNV, and in 44.9% of eyes, often those with more numerous SLG, the SLG were l
187 tter-eye VA) and worse-seeing (worse-eye VA) eye on VRQoL.
188 l new morphological features, such as paired eyes on the head and a dwelling tube.
189                     Data are shown for right eyes only.
190  or blue (585-660 nm) light beginning before eye-opening.
191  can create deformations or movements of the eye or optic nerve, and if such changes could be linked
192 8.6% had a capsulotomy in the AcrySof SN60WF eye (P = .23).
193 as less in glaucomatous eyes than in healthy eyes (P<0.001).
194 ed with nepafenac-treated eyes (6 eyes vs. 1 eye; P = 0.04); no eyes showed IOP elevation of more tha
195  visual acuity (32.1%; n = 317), generalized eye pain (7.4%; n = 73), visual field disturbance (4.3%;
196                                          One eye per participant was included.
197                  Four AS-OCT images from one eye per subject were analyzed and parameters describing
198 re asked to perform 1 VF home assessment per eye, per month, for 6 months (12 tests total).
199 otophore similar to those seen in crustacean eyes, providing further evidence that photophores are li
200 .6) (both p < 0.001), with no differences in eyes receiving >=4 injections (5.9 vs 5.1 respectively,
201                                              Eyes receiving aflibercept showed a lower mean VA (mean
202                             StudyPopulation: Eyes receiving intravitreal anti-vascular endothelial gr
203 in BCVA after the primary surgery, whereas 1 eye remained stable.
204 evere categories included 41, 89, 97, and 63 eyes, respectively.
205                                  Of the 1127 eyes, retinal fluid was present in 32.8%.
206 nce to determine if incorporating the fellow eye's level of visual field damage (MD) or rate signific
207                           At 2 years, 86% of eyes saw >=20/40, 55% saw >=20/25, and 18% saw >=20/20 S
208 (9 mW/cm(2)) irradiation while contralateral eyes served as controls.
209 r weeks after LPI, more prednisolone-treated eyes showed IOP elevation of 6 to 15 mmHg as compared wi
210 reated eyes (6 eyes vs. 1 eye; P = 0.04); no eyes showed IOP elevation of more than 15 mmHg.
211                                  In 38.8% of eyes, SLG were found overlying type 1 MNV, and in 44.9%
212 8 such that the whole structure resembles an eye slip hook.
213  predictions, we found that inputs from both eyes, studied with the transneuronal tracer WGA-HRP, are
214 oints in OSDI), office workers presented dry eye symptoms 4.15 times more frequently than constructio
215 east one of the following signs in the worse eye: TBUT <=10 s, Schirmer score <= 5 mm and fluorescein
216 ss of the SNFL slab was less in glaucomatous eyes than in healthy eyes (P<0.001).
217 ease in macular thickness to >=240 mum in an eye that previously had resolution.
218 ) is a highly mechanosensitive tissue in the eye that regulates intraocular pressure through the cont
219                Kaplan-Meier analysis of 1582 eyes that underwent incisional glaucoma surgery yielded
220                                         Even eyes that were severely ischemic at baseline had no sign
221             In a total of 501 subjects (1002 eyes), the mean age was 43.12 +/- 18.80 years and 347(69
222                          Of the 594 eligible eyes, the number with BCVA of 20/200 or worse at 2 years
223                                Regardless of eye, there was a significant correlation between facial
224 red with patients who did not experience dry eye, those who experienced significant dry eye (ie, dail
225 nd blood flow imaging were performed in both eyes to measure retinal oxygen contents and total retina
226   Eye-movements were recorded using a remote eye tracker.
227       Standard automated perimetry (SAP) and eye tracking perimetry (saccadic vector optokinetic peri
228 , heart rate, skin conductance, respiration, eye tracking, and scalp EEG).
229                    We consider ways in which eye-tracking can be used to determine how animals work w
230 ments in virtual reality (VR) and in-headset eye-tracking to test the impact of active vs. passive vi
231 double dissociation in 129 male humans using eye-tracking, pupillometry and functional magnetic reson
232                               In Taiwan, DM, eye trauma, and dry eye were key predisposing factors fo
233 on was considered as one group, and the same eye treated with a different medication during the obser
234 ing to the eye and the medication so that an eye treated with a particular medication was considered
235 easured intraoperatively using SD-OCT in 293 eyes undergoing lens surgery.
236 s a retrospective comparative case series of eyes undergoing vitrectomy with silicone oil tamponade f
237                                          One eye underwent enucleation at 6 months, and 1 eye became
238 nd uniocular VA in the better-seeing (better-eye VA) and worse-seeing (worse-eye VA) eye on VRQoL.
239 eing (better-eye VA) and worse-seeing (worse-eye VA) eye on VRQoL.
240   Two masked, trained graders analyzed right-eye vitreoretinal findings, including semiautomated quan
241 g as compared with nepafenac-treated eyes (6 eyes vs. 1 eye; P = 0.04); no eyes showed IOP elevation
242 le-operation anatomic success in the initial eye was 82.5% with a mean of 1.2 surgeries (range, 1-4 s
243        Geographic atrophy (GA) in the fellow eye was associated with increased risk of macular atroph
244                             Better and worse eye was determined by 10-2 VF mean deviations (MDs).
245 eeding and neovascular glaucoma in the right eye was seen for a second opinion after parental refusal
246                                         Left eye was unremarkable.
247 tric sensitivity) from the poorer-performing eye was used to investigate the association between PRO
248  average rate of RNFL thinning in uninjected eyes was -0.620 mum/year (P = .029).
249             The mean follow-up period of all eyes was 38.4 +/- 11.2 months (range, 24.2-64.4 months).
250 ncreased light-gathering ability of species' eyes was associated with stronger advancements in reprod
251  in clinical management for culture-positive eyes was based on declining vision (3 eyes), worsening c
252 ) in the aflibercept group at 3 years in all eyes was similar, as was the adjusted mean VA change, +0
253           In Taiwan, DM, eye trauma, and dry eye were key predisposing factors for microbial keratiti
254 ge-related macular degeneration in the study eye were randomized and treated in HAWK/HARRIER.
255                                   Fifty-five eyes were included in the 2q4 group, and 58 eyes were in
256  eyes were included in the 2q4 group, and 58 eyes were included in the 2q8 group.
257                               A total of 103 eyes were included in this study: 51 uncomplicated prima
258                           A total of 263,480 eyes were included, with mean age 71.4 +/- 11.7 years.
259                   After phacoemulsification, eyes were randomized 2:1 to receive a Hydrus Microstent
260 escein angiograms of the affected and fellow eyes were reviewed by 2 authors for characteristic retin
261                A total of 72, 84, and 94% of eyes were within +/- 0.50, +/- 0.75 and +/- 1.00 D of in
262 cal disease (primary angle closure in fellow eye) were analyzed.
263                          Aflibercept-treated eyes, which had borderline worse vision and thicker macu
264                                           In eyes with 4-year follow-up, VA changes from baseline (ET
265 d to a significant reduction of GA growth in eyes with AMD over a 12-month period.
266 lete spatial summation (Ricco's area, RA) in eyes with and without non-pathological, axial myopia.
267                                              Eyes with delayed presentation were more likely to have
268 ion rates did not significantly change among eyes with DME.
269                                         More eyes with early DME gained 10 or more letters and fewer
270                                           In eyes with exudative AMD, previous anti-VEGF treatments d
271                                A total of 70 eyes with GA from 48 participants were included.
272  Spectralis) and FAF images from 97 patients/eyes with GA with dry AMD were collected retrospectively
273                                              Eyes with glaucoma or glaucoma suspect were excluded fro
274 ser ophthalmoscopy (CSLO) images to identify eyes with GVFD and predict quantitative VF mean deviatio
275               Pars plana vitrectomy (PPV) in eyes with history of retinoblastoma has been associated
276 yes with subretinal fluid when compared with eyes with intraretinal fluid.
277 r eyes lost 10 or more letters compared with eyes with late DME (47.4% vs. 33.9% [P = 0.001] and 8.2%
278                    The first cohort included eyes with mild glaucoma (abnormal glaucoma hemifield tes
279 oint decrease in SS; P < 0.05) compared with eyes with mild or moderate glaucoma (-0.67 to -0.75 per
280       Diabetic eyes without DR (n = 138) and eyes with mild/moderate nonproliferative DR (NPDR; n = 1
281 fied various patterns of macular fibrosis in eyes with nAMD.
282  with repeatable glaucomatous SAP defects vs eyes with normal fields.
283                             Deterioration in eyes with or at risk of glaucomatous visual field loss w
284 ds and outcomes of IOL power calculations in eyes with previous LASIK, excimer laser photorefractive
285                                              Eyes with proliferative vitreoretinopathy, giant retinal
286 e the ability of each output to discriminate eyes with repeatable glaucomatous SAP defects vs eyes wi
287  not better than, human graders at detecting eyes with repeatable glaucomatous visual field loss.
288                                              Eyes with scleritis have a greater risk of developing vi
289                                           In eyes with severe disease, 31.6% were classified as progr
290 nd to have a larger impact on reliability in eyes with severe glaucoma (-1.25 per 1-point decrease in
291 e taking 2.1+/-1.3 medications (P = 0.52) in eyes with SLT failure.
292 thickness normalizes faster after surgery in eyes with subretinal fluid when compared with eyes with
293 2 mmHg while taking 2.0+/-1.2 medications in eyes with successful SLT, compared with 19.0+/-5.0 mmHg
294                                              Eyes with uveitis have significantly larger CC MFDS (3-
295 ents with a refractive outcome in the second eye within 1.0 dioptre from the target refraction, at 4
296                                     Diabetic eyes without DR (n = 138) and eyes with mild/moderate no
297 sitive eyes was based on declining vision (3 eyes), worsening clinical examination results (2 eyes),
298 ar), whereas the rate of SVL was 0.61 events/eye-year (95% CI, 0.34-1.02 events/eye-year).
299 e for 2-line or more VA gain was 0.49 events/eye-year (95% confidence interval [CI], 0.26-0.86 events
300 % confidence interval [CI], 0.26-0.86 events/eye-year), whereas the rate of SVL was 0.61 events/eye-y
301 61 events/eye-year (95% CI, 0.34-1.02 events/eye-year).

 
Page Top